Experts forecast this year’s cancer research advances In cancer research, the focus has shifted to precision medicine and much progress…

Discover an easy way to get reproducible analyses, traceability of results and efficient bulk analysis with QIGEN CLC workflows. Stringing…

While the world showed its support for affected people during Breast Cancer Awareness Month, COSMIC’s expert curators were working hard…

Did you know SARS-CoV-2 is shed in the feces of individuals with symptomatic or asymptomatic infection? Viral particles shed into…

We are excited to share with you news of the new QIAGEN CLC Genomics version 22, which offers you many…

The industry-leading NGS variant interpretation and reporting software now includes a new Clinical Validity feature, Dynamic Candidate Disease Identification, NICE…

More mutations, better annotations, confident classifications HGMD Professional 2021.4 is now available, expanding the world’s largest collection of human inherited…

With the scientific research community publishing over two million peer-reviewed articles every year since 2012 (1) and next-generation sequencing fueling a…

If you work in cancer biomarker and target research, chances are you use data from The Cancer Genome Atlas (TCGA)…

Ab initio gene finding is a central step in genome analysis, which must account for the biology of the investigated…

As the technology revolution rages on, the age-old battle rears its head: old vs. new, computers vs. people, tried-and-tested vs….

Ever wonder what goes on behind the scenes in R&D at QIAGEN Digital Insights? Our team of expert scientists is…